Subscribe To
Astrazeneca (azn) set to acquire cincor pharma for $1.3b
AstraZeneca's (AZN) CinCor Pharma buyout is going to add blood pressure drug baxdrostat to its cardiorenal...
January 10, 2023, 9:47 am
Baxter (bax) plans to form standalone kidney care company
Baxter (BAX) plans several strategic actions, including spin-off of renal Care and Acute Therapies glob...
January 9, 2023, 9:47 am
Astrazeneca to acquire cincor for us$1.8bn
AstraZeneca PLC (LSE:AZN) has announced it will acquire US-based biopharmaceutical firm CinCor for approximately US$1.8bn in an effort to boost its tr...
January 9, 2023, 7:09 am
Astrazeneca to buy cincor pharma in $1.8 billion deal
AstraZeneca said the deal, expected to close in the first quarter of 2023, will bolster its cardiorenal...
January 9, 2023, 4:32 am
Astrazeneca will buy u.s.-based cincor for cardiorenal asset
AstraZeneca PLC said Monday that it has agreed to buy CinCor Pharma, Inc., acquiring global rights to the latter's baxdrostat cardio...
January 9, 2023, 2:29 am
: baxter stock drops on plan to restructure and spin off kidney care unit
Hospital products company shares drop as it readies a restructuring plan and sets plan to spin off its renal...
January 6, 2023, 1:40 pm
: baxter to spin off kidney care unit as part of a flurry of strategic actions
Baxter International Inc. BAX said Friday it plans to embark on a tax-free spin off to shareholders of its ren...
January 6, 2023, 12:17 pm
Baxter stock drops on plan to restructure and spin off kidney care unit
Baxter International Inc. said Friday it plans to embark on a tax-free spin off to shareholders of its renal<...
January 6, 2023, 8:40 am
Hyperkalemia, congestive heart failure, and aldosterone receptor antagonism
Hyperkalemia is a common occurrence in patients with congestive heart failure, particularly when renal ...
January 3, 2023, 8:14 am
Biocryst to discontinue development of drug
Shares of BioCryst Pharmaceuticals Inc. were down about 5% in premarket trading on Thursday after the company said it halted development of BCX9930, w...
December 15, 2022, 8:52 am
Exponentiation in incidences of chronic diseases to drive the continuous renal replacement therapy market, reaching us$ 1.68 bn at a cagr of 7.7% in the forecast period 2021-27 by future market insigh
Increase in Number of Dialysis Centers Fueling Continuous renal Replacement Therapy Market. Key Players...
December 12, 2022, 2:30 am
Exponentiation in incidences of chronic diseases to drive the continuous renal replacement therapy market, reaching us$ 1.68 bn at a cagr of 7.7% in the forecast period 2021-27 by future market insigh
Increase in Number of Dialysis Centers Fueling Continuous renal Replacement Therapy Market. Key Players...
December 12, 2022, 2:30 am
Exponentiation in incidences of chronic diseases to drive the continuous renal replacement therapy market, reaching us$ 1.68 bn at a cagr of 7.7% in the forecast period 2021-27 by future market insigh
Increase in Number of Dialysis Centers Fueling Continuous renal Replacement Therapy Market. Key Players...
December 12, 2022, 2:30 am
renalytix plc (rnlx) q1 2023 earnings call transcript
renalytix Plc (NASDAQ:RNLX ) Q1 2023 Earnings Conference Call November 30, 2022 8:30 AM ET Company Part...
November 30, 2022, 1:26 pm
$fme : fresenius medical care enters monthly buying area
Fresenius Medical Care is a German American healthcare company. It is one of the four devisions of Fresenius SE & Co. KGaA. The company provides kidne...
November 21, 2022, 6:28 pm
Microsoft co-founder paul allen's art collection sells for an unprecedented $1.5 billion
The unprecedented $1.5 billion sale of the late Microsoft MSFT, +1.70% co-founder Paul Allen's masterpiece collection Wednesday evening at Christie's ...
November 12, 2022, 8:15 am
3 stocks that are screaming buys right now
Few things are more exhilarating than finding “screaming buys” in the stock market. When everything lines up and you know you're buying a stock at...
August 26, 2022, 12:17 pm
Merck (mrk) gets fda fast track tag for anticoagulant therapy
A phase II study is ongoing on Merck's (MRK) MK-2060 in people with end-stage renal disease receiving h...
August 24, 2022, 12:47 pm
renalytix: the investment case is shot
renalytix has a great product but a lousy cost base. I think that will force it to raise lots of new fu...
July 25, 2022, 2:16 am
Natera to present new signatera™ clinical data across multiple cancer types at the 2022 asco annual meeting
NSCLC: ctDNA data in stage I-III patients showed 82% detection pre-treatment and was able to identify 100% of relapses prior to radiographic imaging...
May 31, 2022, 8:33 am